EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Study of Maternal Patients Diagnosed with Inborn Errors of Metabolism Due to Positive Newborn Mass Screening in Their Newborns

Takanori Onuki iD, Shota Hiroshima, Kentaro Sawano, Nao Shibata, Yohei Ogawa, Keisuke Nagasaki iD, Hiromi Nyuzuki

Children · 03.08.2023 · 10 (8) · 1341

DOI: 10.3390/children10081341 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Children, online erschienen am 03.08.2023. Verfasst von Takanori Onuki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatrics, Department of Homeostatic Regulation and Development, Niigata University Graduate School of Medicine and Dental Sciences, Nii…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There are reports of mothers being diagnosed with inborn errors of metabolism (IEM) via positive newborn screening (NBS) of their newborns. Mothers with IEM are often considered to have mild cases of little pathological significance. Based in Niigata Prefecture, this study aimed to investigate mothers newly diagnosed with IEM via positive NBS in their newborns using tandem mass spectrometry, and to clarify the disease frequency and severity.

Methods

This was a single-institution, population-based, retrospective study. The subjects were mothers whose newborns had false-positive NBS, among 80,410 newborns who underwent NBS between April 2016 and May 2021. Result: there were 3 new mothers were diagnosed with IEM (2 with primary systemic carnitine deficiency (PCD) and 1 with 3-methylcrotonyl-CoA carboxylase deficiency) out of 5 who underwent examination among 18 false positives. The opportunity for diagnosis was low C0 and high C5-OH acylcarnitine levels in their newborn. Two novel SLC22A5 variants (c.1063T > C/c.1266A > G) were identified in patients with PCD. None of the patients had any complications at the time of diagnosis, but two patients showed improvement in fatigue and headache after taking oral carnitine.

Conclusion

New mothers with IEM cannot be considered as mild cases and need to be treated when necessary. The two novel SLC22A5 variants further expand the variant spectrum of PCD.

Schlagwörter

Stichwörter der Autor:innen

3-Methylcrotonyl-CoA carboxylase deficiencyfalse-positive newborn screeningmaternal inborn errors of metabolismnewborn screeningprimary systemic carnitine deficiency

Autor:innen und Institutionen

  • Division of Pediatrics, Department of Homeostatic Regulation and Development, Niigata University Graduate School of Medicine and Dental Sciences, Niigata 951-8510, Japan.

ORCID-Profile: Takanori Onuki, Keisuke Nagasaki

Zitieren

APA

Onuki, T., Hiroshima, S., Sawano, K., Shibata, N., Ogawa, Y., Nagasaki, K., & Nyuzuki, H. (2023). A Study of Maternal Patients Diagnosed with Inborn Errors of Metabolism Due to Positive Newborn Mass Screening in Their Newborns. Children, 10(8), 1341. https://doi.org/10.3390/children10081341

Vancouver

Onuki T, Hiroshima S, Sawano K, Shibata N, Ogawa Y, Nagasaki K, et al. A Study of Maternal Patients Diagnosed with Inborn Errors of Metabolism Due to Positive Newborn Mass Screening in Their Newborns. Children. 2023;10(8):1341. doi:10.3390/children10081341

BibTeX
@article{Onuki2023,
  author = {Onuki, Takanori and Hiroshima, Shota and Sawano, Kentaro and Shibata, Nao and Ogawa, Yohei and Nagasaki, Keisuke and Nyuzuki, Hiromi},
  title = {A Study of Maternal Patients Diagnosed with Inborn Errors of Metabolism Due to Positive Newborn Mass Screening in Their Newborns},
  journal = {Children},
  year = {2023},
  volume = {10},
  number = {8},
  pages = {1341},
  doi = {10.3390/children10081341}
}
Kostenlos starten →